Dr. Mirjam Mol-Arts

AC member

Dr. Mirjam Mol-Arts has an extensive career in the pharmaceutical industry, most recently as former Chief Science & Medical Officer at Ferring Pharmaceuticals. Prior to that she served from 2014 till 2018 as CEO of the Pivot Park in Oss, the Netherlands. She has worked as VP Medical Affairs within Organon NV, Schering-Plough and Clinical Development Director Merck/MSD in women’s health and endocrinology. Currently dr. Mol-Arts is a Supervisory Board Member of Organon, Lygature and Holland PTC. 

Our other team members

We are a venture capital firm specializing in seed investments for innovative early-stage companies. Curie Capital typically takes on the role of lead investor. Our team comprises life science experts and business analysts who offer guidance to life science companies throughout the entire research and development process.

Han de Groot


Mariette van der Velden


Thom Frielink



Junior partner